Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-012252
Filing Date
2009-05-14
Accepted
2009-05-14 16:21:11
Documents
1
Period of Report
2009-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3876
  Complete submission text file 0001140361-09-012252.txt   5728
Mailing Address 420 LEXINGTON AVE SUITE 408 NEW YORK NY 10170
Business Address 420 LEXINGTON AVE SUITE 408 NEW YORK NY 10170 2126729100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30952 STEEPLECHASE DRIVE SAN JUAN CAPISTRANO CA 92675
Business Address
Antal James (Reporting) CIK: 0001315696 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23047 | Film No.: 09826940